Age for Discontinuing Pap Smear Screening
Women should discontinue cervical cancer screening after age 65 years if they have had 3 consecutive negative cytology tests or 2 consecutive negative cotest results within the 10-year period before ceasing screening, with the most recent test occurring within the last 5 years. 1
Criteria for Discontinuing Screening
The decision to stop screening at age 65 is based on several key factors:
Adequate prior screening history is defined as:
- 3 consecutive negative cytology (Pap) tests OR
- 2 consecutive negative HPV-cytology cotests within the past 10 years
- Most recent test must have occurred within the last 5 years 1
Once screening is discontinued, it should not resume for any reason, including if a woman has a new sexual partner 1
Special Considerations and Exceptions
Certain women should continue screening beyond age 65:
Women with a history of CIN2, CIN3, or adenocarcinoma in situ should continue routine screening for at least 20 years after treatment, even if this extends screening past age 65 1
Women who have not been adequately screened previously should continue screening until they meet the criteria for discontinuation 1
Women at higher risk should continue screening beyond age 65, including those who:
- Have a history of cervical cancer
- Were exposed to diethylstilbestrol (DES) in utero
- Are immunocompromised (organ transplantation, chemotherapy, chronic corticosteroid treatment)
- Are HIV-positive 1
Women with Hysterectomy
Women who have had a total hysterectomy with removal of the cervix and have no history of high-grade precancerous lesions or cervical cancer should discontinue screening 1
Women who have had a hysterectomy but still have their cervix should continue screening according to age-appropriate guidelines 1
Women who have had a hysterectomy with removal of the cervix but have a history of CIN2 or more severe diagnosis should continue screening 1
Evidence and Rationale
The recommendation to discontinue screening at age 65 is based on evidence that:
The risk of developing cervical cancer after age 65 is very low in adequately screened women
Modeling data suggest that continued testing of previously screened women reduces the risk of cervical cancer mortality by only 0.18% at age 65 and 0.06% at age 74 1
However, some research suggests higher rates of abnormal Pap smears in certain elderly populations, particularly among Black women and other minority groups 2
Common Pitfalls to Avoid
Continuing unnecessary screening: Approximately 40.8% of women over 70 years still receive Pap smears despite guidelines recommending discontinuation 3
Provider-driven overscreening: Nearly 40% of women ≥70 years report receiving a recommendation for Pap testing from their provider in the past year 3
Stopping screening too early: Women without adequate prior screening history should not discontinue at age 65 1
Failing to recognize high-risk groups: Women with history of high-grade lesions or other risk factors need continued screening 1
Following these evidence-based guidelines will help optimize cervical cancer screening by balancing the benefits of early detection against the potential harms of unnecessary procedures in older women.